Works by Willman, Cheryl L.


Results: 37
    1

    Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia.

    Published in:
    JAMA: Journal of the American Medical Association, 2009, v. 301, n. 4, p. 393, doi. 10.1001/jama.2009.7
    By:
    • Yang, Jun J.;
    • Cheng, Cheng;
    • Yang, Wenjian;
    • Pei, Dequing;
    • Cao, Xueyuan;
    • Fan, Yiping;
    • Pounds, Stanley B.;
    • Neale, Geoffrey;
    • Treviño, Lisa R.;
    • French, Deborah;
    • Campana, Dario;
    • Downing, James R.;
    • Evans, William E.;
    • Pui, Ching-Hon;
    • Devidas, Meenakshi;
    • Bowman, W. P.;
    • Camitta, Bruce M.;
    • Willman, Cheryl L.;
    • Davies, Stella M.;
    • Borowitz, Michael J.
    Publication type:
    Article
    2

    A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research.

    Published in:
    JAMA Health Forum, 2022, v. 3, n. 1, p. e220603, doi. 10.1001/jamahealthforum.2022.0603
    By:
    • Rebbeck, Timothy R.;
    • Bridges, John F. P.;
    • Mack, Jennifer W.;
    • Gray, Stacy W.;
    • Trent, Jeffrey M.;
    • George, Suzanne;
    • Crossnohere, Norah L.;
    • Paskett, Electra D.;
    • Painter, Corrie A.;
    • Wagle, Nikhil;
    • Kano, Miria;
    • Nez Henderson, Patricia;
    • Henderson, Jeffrey A.;
    • Mishra, Shiraz I.;
    • Willman, Cheryl L.;
    • Sussman, Andrew L.
    Publication type:
    Article
    3

    Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 10, p. 733, doi. 10.1093/jnci/djt042
    By:
    • Heng Xu;
    • Wenjian Yang;
    • Perez-Andreu, Virginia;
    • Devidas, Meenakshi;
    • Yiping Fan;
    • Cheng Cheng;
    • Deqing Pei;
    • Scheet, Paul;
    • Burchard, Esteban Gonzalez;
    • Eng, Celeste;
    • Huntsman, Scott;
    • Torgerson, Dara G.;
    • Dean, Michael;
    • Winick, Naomi J.;
    • Martin, Paul L.;
    • Camitta, Bruce M.;
    • Bowman, W. Paul;
    • Willman, Cheryl L.;
    • Carroll, William L.;
    • Mullighan, Charles G.
    Publication type:
    Article
    4

    Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.

    Published in:
    Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00461-0
    By:
    • Pogosova-Agadjanyan, Era L.;
    • Hua, Xing;
    • Othus, Megan;
    • Appelbaum, Frederick R.;
    • Chauncey, Thomas R.;
    • Erba, Harry P.;
    • Fitzgibbon, Matthew P.;
    • Jenkins, Isaac C.;
    • Fang, Min;
    • Lee, Stanley C.;
    • Moseley, Anna;
    • Naru, Jasmine;
    • Radich, Jerald P.;
    • Smith, Jenny L.;
    • Willborg, Brooke E.;
    • Willman, Cheryl L.;
    • Wu, Feinan;
    • Meshinchi, Soheil;
    • Stirewalt, Derek L.
    Publication type:
    Article
    5

    AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.

    Published in:
    Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00208-1
    By:
    • Pogosova-Agadjanyan, Era L.;
    • Moseley, Anna;
    • Othus, Megan;
    • Appelbaum, Frederick R.;
    • Chauncey, Thomas R.;
    • Chen, I-Ming L.;
    • Erba, Harry P.;
    • Godwin, John E.;
    • Jenkins, Isaac C.;
    • Fang, Min;
    • Huynh, Mike;
    • Kopecky, Kenneth J.;
    • List, Alan F.;
    • Naru, Jasmine;
    • Radich, Jerald P.;
    • Stevens, Emily;
    • Willborg, Brooke E.;
    • Willman, Cheryl L.;
    • Wood, Brent L.;
    • Zhang, Qing
    Publication type:
    Article
    6
    7

    BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.

    Published in:
    Nature Medicine, 2013, v. 19, n. 8, p. 1014, doi. 10.1038/nm.3247
    By:
    • Swaminathan, Srividya;
    • Huang, Chuanxin;
    • Geng, Huimin;
    • Chen, Zhengshan;
    • Harvey, Richard;
    • Kang, Huining;
    • Ng, Carina;
    • Titz, Björn;
    • Hurtz, Christian;
    • Sadiyah, Mohammed Firas;
    • Nowak, Daniel;
    • Thoennissen, Gabriela B;
    • Rand, Vikki;
    • Graeber, Thomas G;
    • Koeffler, H Phillip;
    • Carroll, William L;
    • Willman, Cheryl L;
    • Hall, Andrew G;
    • Igarashi, Kazuhiko;
    • Melnick, Ari
    Publication type:
    Article
    8
    9

    Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.

    Published in:
    Nature, 2015, v. 521, n. 7552, p. 357, doi. 10.1038/nature14231
    By:
    • Chen, Zhengshan;
    • Shojaee, Seyedmehdi;
    • Buchner, Maike;
    • Geng, Huimin;
    • Lee, Jae Woong;
    • Klemm, Lars;
    • Titz, Björn;
    • Graeber, Thomas G.;
    • Park, Eugene;
    • Tan, Ying Xim;
    • Satterthwaite, Anne;
    • Paietta, Elisabeth;
    • Hunger, Stephen P.;
    • Willman, Cheryl L.;
    • Melnick, Ari;
    • Loh, Mignon L.;
    • Jung, Jae U.;
    • Coligan, John E.;
    • Bolland, Silvia;
    • Mak, Tak W.
    Publication type:
    Article
    10
    11

    At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 37, doi. 10.1111/bjh.16616
    By:
    • Ganzel, Chezi;
    • Wang, Xin V.;
    • Rowe, Jacob M.;
    • Richards, Susan M.;
    • Buck, Georgina;
    • Marks, David I.;
    • Litzow, Mark R.;
    • Paietta, Elisabeth M.;
    • Foroni, Letizia;
    • Luger, Selina M.;
    • Willman, Cheryl L.;
    • Mullighan, Charles G.;
    • Roberts, Kathryn G.;
    • Wiernik, Peter H.;
    • Douer, Dan;
    • Lazarus, Hillard M.;
    • Tallman, Martin S.;
    • Goldstone, Anthony H.
    Publication type:
    Article
    12

    Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 4, p. 497, doi. 10.1111/bjh.12775
    By:
    • Coutre, Steven E.;
    • Othus, Megan;
    • Powell, Bayard;
    • Willman, Cheryl L.;
    • Stock, Wendy;
    • Paietta, Elisabeth;
    • Levitan, Denise;
    • Wetzler, Meir;
    • Attar, Eyal C.;
    • Altman, Jessica K.;
    • Gore, Steven D.;
    • Maher, Tracy;
    • Kopecky, Kenneth J.;
    • Tallman, Martin S.;
    • Larson, Richard A.;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    13

    A model for prediction of FLT3- ITD and NPM1 (without FLT3- ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 1, p. 130, doi. 10.1111/bjh.12450
    By:
    • Ostronoff, Fabiana;
    • Othus, Megan;
    • Kantarjian, Hagop M.;
    • Meshinchi, Soheil;
    • Ravandi, Farhad;
    • Hendrie, Paul C.;
    • Faderl, Stefan;
    • Becker, Pamela S.;
    • Cortes, Jorge E.;
    • Pagel, John M.;
    • Petersdorf, Stephen H.;
    • Godwin, John E.;
    • Willman, Cheryl L.;
    • Pierce, Sherry A.;
    • List, Alan F.;
    • Sandhu, Ravinder K.;
    • Walter, Roland B.;
    • Stirewalt, Derek L.;
    • Appelbaum, Frederick R.;
    • Estey, Elihu H.
    Publication type:
    Article
    14

    Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2010, v. 148, n. 1, p. 48, doi. 10.1111/j.1365-2141.2009.07919.x
    By:
    • Chauncey, Thomas R.;
    • Gundacker, Holly;
    • Shadman, Mazyar;
    • List, Alan F.;
    • Dakhil, Shaker R.;
    • Erba, Harry P.;
    • Slovak, Marilyn L.;
    • I-Ming Chen;
    • Willman, Cheryl L.;
    • Kopecky, Kenneth J.;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    15

    Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia.

    Published in:
    Genes, Chromosomes & Cancer, 2005, v. 44, n. 3, p. 279, doi. 10.1002/gcc.20236
    By:
    • David A. Sweetser;
    • Andrew J. Peniket;
    • Christina Haaland;
    • Adam A. Blomberg;
    • Yuntian Zhang;
    • Syed Tanweer Zaidi;
    • Farshid Dayyani;
    • Zheng Zhao;
    • Nyla A. Heerema;
    • Jacqueline Boultwood;
    • Gordon W. Dewald;
    • Elisabeth Paietta;
    • Marilyn L. Slovak;
    • Cheryl L. Willman;
    • James S. Wainscoat;
    • Irwin D. Bernstein;
    • Sarah B. Daly
    Publication type:
    Article
    16
    17
    18

    Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500).

    Published in:
    American Journal of Hematology, 2007, v. 82, n. 12, p. 1056, doi. 10.1002/ajh.20994
    By:
    • Petersdorf, Stephen H.;
    • Rankin, Cathryn;
    • Head, David R.;
    • Terebelo, Howard R.;
    • Willman, Cheryl L.;
    • Balcerzak, Stanley P.;
    • Karnad, Anand B.;
    • Dakhil, Shaker R.;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    19

    Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia.

    Published in:
    PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0118485
    By:
    • Cesano, Alessandra;
    • Willman, Cheryl L.;
    • Kopecky, Kenneth J.;
    • Gayko, Urte;
    • Putta, Santosh;
    • Louie, Brent;
    • Westfall, Matt;
    • Purvis, Norman;
    • Spellmeyer, David C.;
    • Marimpietri, Carol;
    • Cohen, Aileen C.;
    • Hackett, James;
    • Shi, Jing;
    • Walker, Michael G.;
    • Sun, Zhuoxin;
    • Paietta, Elisabeth;
    • Tallman, Martin S.;
    • Cripe, Larry D.;
    • Atwater, Susan;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    20
    21
    22

    Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3).

    Published in:
    Pediatric Blood & Cancer, 2015, v. 62, n. 3, p. 419, doi. 10.1002/pbc.25322
    By:
    • Dreyer, ZoAnn E.;
    • Hilden, Joanne M.;
    • Jones, Tamekia L.;
    • Devidas, Meenakshi;
    • Winick, Naomi J.;
    • Willman, Cheryl L.;
    • Harvey, Richard C.;
    • Chen, I‐Ming;
    • Behm, Fred G.;
    • Pullen, Jeanette;
    • Wood, Brent L.;
    • Carroll, Andrew J.;
    • Heerema, Nyla A.;
    • Felix, Carolyn A.;
    • Robinson, Blaine;
    • Reaman, Gregory H.;
    • Salzer, Wanda L.;
    • Hunger, Stephen P.;
    • Carroll, William L.;
    • Camitta, Bruce M.
    Publication type:
    Article
    23
    24

    Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906.

    Published in:
    Pediatric Blood & Cancer, 2011, v. 57, n. 4, p. 569, doi. 10.1002/pbc.22944
    By:
    • Bowman, W. Paul;
    • Larsen, Eric L.;
    • Devidas, Meenakshi;
    • Linda, Stephen B.;
    • Blach, Laurie;
    • Carroll, Andrew J.;
    • Carroll, William L.;
    • Pullen, D. Jeanette;
    • Shuster, Jonathan;
    • Willman, Cheryl L.;
    • Winick, Naomi;
    • Camitta, Bruce M.;
    • Hunger, Stephen P.;
    • Borowitz, Michael J.
    Publication type:
    Article
    25

    Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.

    Published in:
    Nature Genetics, 2011, v. 43, n. 3, p. 237, doi. 10.1038/ng.763
    By:
    • Yang, Jun J.;
    • Cheng Cheng;
    • Devidas, Meenakshi;
    • Xueyuan Cao;
    • Yiping Fan;
    • Campana, Dario;
    • Wenjian Yang;
    • Neale, Geoff;
    • Cox, Nancy J.;
    • Scheet, Paul;
    • Borowitz, Michael J.;
    • Winick, Naomi J.;
    • Martin, Paul L.;
    • Willman, Cheryl L.;
    • Bowman, W. Paul;
    • Camitta, Bruce M.;
    • Carroll, Andrew;
    • Reaman, Gregory H.;
    • Carroll, William L.;
    • Loh, Mignon
    Publication type:
    Article
    26

    Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia.

    Published in:
    Nature Genetics, 2009, v. 41, n. 11, p. 1243, doi. 10.1038/ng.469
    By:
    • Mullighan, Charles G.;
    • Collins-Underwood, J. Racquel;
    • Phillips, Letha A. A.;
    • Loudin, Michael G.;
    • Wei Liu;
    • Jinghui Zhang;
    • Jing Ma;
    • Coustan-Smith, Elaine;
    • Harvey, Richard C.;
    • Willman, Cheryl L.;
    • Mikhail, Fady M.;
    • Meyer, Julia;
    • Carroll, Andrew J.;
    • Williams, Richard T.;
    • Jinjun Cheng;
    • Heerema, Nyla A.;
    • Basso, Giuseppe;
    • Pession, Andrea;
    • Ching-Hon Pui;
    • Raimondi, Susana C.
    Publication type:
    Article
    27

    Leadership Diversity and Development in the Nation's Cancer Centers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 9, p. 1214, doi. 10.1093/jnci/djac121
    By:
    • Lerman, Caryn;
    • Hughes-Halbert, Chanita;
    • Falcone, Mary;
    • Gosky, David M;
    • Jensen, Roy A;
    • Lee, Kelvin P;
    • Mitchell, Edith;
    • Odunsi, Kunle;
    • Pegher, Jennifer W;
    • Rodriguez, Elisa;
    • Sanchez, Yolanda;
    • Shaw, Reuben;
    • Weiner, George;
    • Willman, Cheryl L
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    Trisomy 11: an association with stem/progenitor cell immunophenotype.

    Published in:
    British Journal of Haematology, 1995, v. 90, n. 2, p. 266, doi. 10.1111/j.1365-2141.1995.tb05146.x
    By:
    • SLOVAK, MARILYN L.;
    • TRAWEEK, S. THOMAS;
    • WILLMAN, CHERYL L.;
    • HEAD, DAVID R.;
    • KOPECKY, KENNETH J.;
    • MAGENIS, R. ELLEN;
    • APPELBAUM, FREDERICK R.;
    • FORMAN, STEPHEN J.
    Publication type:
    Article
    36

    The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

    Published in:
    2011
    By:
    • Ashley, Carlee E.;
    • Carnes, Eric C.;
    • Phillips, Genevieve K.;
    • Padilla, David;
    • Durfee, Paul N.;
    • Brown, Page A.;
    • Hanna, Tracey N.;
    • Juewen Liu;
    • Phillips, Brandy;
    • Carter, Mark B.;
    • Carroll, Nick J.;
    • Xingmao Jiang;
    • Dunphy, Darren R.;
    • Willman, Cheryl L.;
    • Petsev, Dimiter N.;
    • Evans, Deborah G.;
    • Parikh, Atul N.;
    • Chackerian, Bryce;
    • Wharton, Walker;
    • Peabody, David S.
    Publication type:
    Correction Notice
    37

    The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

    Published in:
    Nature Materials, 2011, v. 10, n. 5, p. 389, doi. 10.1038/nmat2992
    By:
    • Ashley, Carlee E.;
    • Carnes, Eric C.;
    • Phillips, Genevieve K.;
    • Padilla, David;
    • Durfee, Paul N.;
    • Brown, Page A.;
    • Hanna, Tracey N.;
    • Juewen Liu;
    • Phillips, Brandy;
    • Carter, Mark B.;
    • Carroll, Nick J.;
    • Xingmao Jiang;
    • Dunphy, Darren R.;
    • Willman, Cheryl L.;
    • Petsev, Dimiter N.;
    • Evans, Deborah G.;
    • Parikh, Atul N.;
    • Chackerian, Bryce;
    • Wharton, Walker;
    • Peabody, David S.
    Publication type:
    Article